Table 1: Patient characteristics before Rituximab.

Patient number Histological diagnosis from renal biopsy Type of nephrotic syndrome Sex Age at disease diagnosis Years of disease before treatment Previous treatments Use of ACEI or ARB before Rituximab
1 MCD SDNS M 2 11 Pred/TAC/MMF No
2 MCD SDNS F 3 15 2 MCD SDNS F 3 15 Pred/CsA/MMF/Oral CTX Yes Yes
3 FSGS SDNS M 2 18 Pred/TAC/MMF/Oral CTX No
4 FSGS SDNS F 9 8 Pred/TAC/MMF/Oral + IV CTX No
5 MCD SDNS M 4 13 Pred/TAC/MMF No
6 MCD SDNS M 10 3 Pred/TAC/MMF/Oral CTX Yes
7 C1Q nephropathy with FSGS SDNS M 2 2 Pred/TAC/MMF/IV CTX Yes
8 FSGS SRNS M 2 11 Pred/CsA/MMF Yes
9 MCD SDNS M 2 11 Pred/CsA/MMF/Oral CTX No
10 C1Q nephropathy SRNS F 2 6 Pred/TAC/MMF/Oral CTX No
11 MCD SDNS M 6 7 Pred/CsA/MMF No

ACEI: Angiotensin Converting Enzyme Inhibitor; ARB: Angiotensin Receptor Blocker; CsA: Cyclosporin A; CTX: Cyclophosphamide; FGS: Focal Glomerulosclerosis; FSGS: Focal Segmental Glomerulosclerosis; MCD: Minimal Change Disease; MMF: Mycophenolate Mofetil; Pred: Prednisolone; SDNS: Steroid Dependent Nephrotic Syndrome; SRNS: Steroid Resistant Nephrotic Syndrome; TAC: Tacrolimus.